“A Phase 3 Trial of Semagacestat for Treatment of Alzheimer’s Disease,” by Rachelle S. Doody, Rema Raman, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul S. Aisen, Eric Siemers, Gopalan Sethuraman, and Richard Mohs, for the Alzheimer’s Disease Cooperative Study Steering Committee and the Semagacestat Study Group (Vol. 369, No. 4, July 25, 2013, p. 341-350).
July 25, 2013
No Comments
No comments yet.
RSS feed for comments on this post.
Sorry, the comment form is closed at this time.
